- The administration of the booster dose is optional and free under the National COVID-19 Immunisation Programme (PICK).
- The heterologous booster dose will be administered off-label to eligible recipients of the Sinovac vaccination beginning tomorrow in stages throughout the country.
Eligible Sinovac Vaccine Recipients To Receive Pfizer Booster Dose After Three Months Starting Today
The Ministry of Health (MOH) will extend the Comirnaty (Pfizer-BionTech) COVID-19 vaccine booster dose to those who have completed their Sinovac vaccination after at least three months.
Health Minister Khairy Jamaluddin said that the heterologous booster dose will be administered off-label to eligible recipients of the Sinovac vaccination beginning today in stages throughout the country.
“For the start, the booster shot would be administered on individuals aged 60 and above based on the advice of Strategic Advisory Group Experts on Immunisation (SAGE) from the World Health Organisation (WHO) which met on Oct 4 to 7.”
“The dispensing would become a subgroup study in the study of The Real World Evaluation of COVID-19 Vaccination (RECoVaM) and the study on Serious Adverse Effects After Vaccination (SAFECOVAC) which is for all booster dose recipients,” Khairy said at a media conference.
According to Khairy, the administration of the booster dose is optional and free under the National COVID-19 Immunisation Programme (PICK), with the goal of ensuring the best possible protection for COVID-19 users in Malaysia.
According to him, the effort will be led by private medical practitioners and coordinated by Protect Health Corporation Sdn Bhd.
“Eligible Individuals would be informed via MySejahtera application and through Short Message Service (SMS) to the telephone number of the individuals who do not have MySejahtera.”
“The method of booster dose appointment would be improved from time to time and soon vaccine recipients would be able to make appointments through a system being developed by MOH,” he added.
Earlier, the Health Minister said that the booster dose was implemented nationally on October 13 using the Comirnaty (Pfizer) vaccine, with 47,728 users as of October 19.
He said that at the time, recipients of the Comirnaty (Pfizer) vaccination receive a booster dose at least six months later, with priority given to frontliners (health and security), people aged 60 and above, and those with comorbidity.
source - borneo post online
Regarding the pandemic situation for the 41st epid week (Oct 10 to 16), Khairy stated that the total admission of COVID-19 patients to public hospitals and COVID-19 Quarantine and Low-Risk Treatment Centres (PKRC) for the Central Zone (Selangor, Kuala Lumpur, and Putrajaya) has started to show a rising trend seeing as interstate travel was permitted on Oct 11.
He said that the situation is the same in Sarawak, particularly for Category 3, 4, and 5 patients, now that interstate travel is permitted.
“Similarly, the trend of COVID-19 patients in categories 3,4 and 5 in the Southern Zone in which Negeri Sembilan had started to show an increasing trend in the 40th epidemic week,” he said.
Meanwhile, Khairy announced the start of the COVID-19 National Testing Strategy, which will examine the test strategy for COVID-19 in more detail, such as the circumstances required for the COVID-19 test.
He said that the document will be published on the MOH website tomorrow (October 22).
“… at the workplace, school, university, concert, conference, stadium and so on by clearly stating when you need to be tested, how often you need to be tested. The launch (strategy) would give a clearer picture to the people on when one should carry out COVID-19 test and in what context one should take the COVID-19 test,” Khairy emphasised.